Strong Early Safety, Efficacy Data for Novel BCMA-Targeted Therapy TNB-383B to Treat Relapsed/Refractory Myeloma

Press/Media

Period	7 Dec 2020

Media coverage

Title	Strong Early Safety, Efficacy Data for Novel BCMA-Targeted Therapy TNB-383B to Treat Relapsed/Refractory Myeloma
Media name/outlet	Cancernetwork.com
Country/Territory	United States
Date	7/12/20
URL	https://www.cancernetwork.com/view/strong-early-safety-efficacy-data-for-novel-bcma-targeted-therapy-tnb-383b-to-treat-relapsed-refractory-myeloma
Persons	Cesar Rodriguez